Back to Trades
Chen Bihua
InsiderCIK 0001599214
Total Volume
$145.4M
10 filings
Purchases
$13.0M
2 buy txns
Sales
$46.9M
5 sell txns
Net Activity
-$33.9M
net sold
Profile
- Filings
- 10
- Buy transactions
- 2
- Sell transactions
- 5
- Companies
- 5
- Active
- 2025–2026
Across 10 filings between 2025–2026, Chen Bihua has disclosed $145.4M in transactions — spread across 5 companies. Their disclosed trades are net selling — $13.0M in buys and $46.9M in sells. The largest single open-market purchase on record is $8.0M in Helix Acquisition Corp. III. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Aug 10 | BLSM BlossomHill Therapeutics, Inc. | Chen Bihua | Insider | Buy | $5.0M |
| Aug 6 | BLSM BlossomHill Therapeutics, Inc. | Chen Bihua | Insider | Other | $0 |
| Jul 6 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Director, 10% Owner | Other | $0 |
| Jun 18 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Insider | Award | $244.8K |
| Jan 28 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Buy | $8.0M |
| Jan 26 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Grant | $5.0M |
| Jan 22 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Other | $0 |
| Oct 1 | MLTX MoonLake Immunotherapeutics | Chen Bihua | Insider | Sell | $46.9M |
| Aug 13 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Director, 10% Owner | Grant | $75.0M |
| Aug 1 | BMEA Biomea Fusion, Inc. | Chen Bihua | Insider | Other | $0 |
10 filings